|

mFOLFOX6 Clinical Trials

8 actively recruiting trials across 1 location

No change since May 2026

Also known as: 5-Fluorouracil, 5-fluorouracil, Consolidation chemotherapy, Folinic acid, Oxaliplatin, 5-fluorouracil (FU), Leucovorin +2 more

Pipeline

Phase 2: 3Phase 3: 3Phase 1/2: 2

Top Sponsors

  • Zhejiang Cancer Hospital1
  • Sun Yat-sen University1
  • National Cheng-Kung University Hospital1
  • Menoufia University1
  • Jun Huang1

Indications

  • Cancer8
  • Colorectal Cancer3
  • Metastatic HER2 Positive Gastroesophageal Junction Cancer1
  • pMMR/MSS Adenocarcinoma of the Colon or Rectum1
  • Patients With Resected Stage II Colon Cancer1

Other7 trials

CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II
Phase 3
Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients
Phase 1/2
Neoadjuvant FOLFIRINOX and Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer Patients
Phase 2
Neoadjuvant Treatment With mFOLFOXIRI Plus Cadonilimab (AK104) Versus mFOLFOX6 in Locally Advanced Colorectal Cancer
Phase 2
Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)
Phase 3
Total Neoadjuvant Therapy in Rectal Cancer
Phase 2
mFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC
Phase 3

Phoenix, Arizona1 trial

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Mayo Clinic-Arizona

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.